Copyright
©The Author(s) 2022.
World J Stem Cells. Jul 26, 2022; 14(7): 539-555
Published online Jul 26, 2022. doi: 10.4252/wjsc.v14.i7.539
Published online Jul 26, 2022. doi: 10.4252/wjsc.v14.i7.539
Figure 5 c-Myc binds to the miR-3682-3p promoter region and promotes its transcriptional activation.
A: Gene set enrichment analysis revealed that miR-3682-3p is positively associated with c-Myc; B: Bioinformatic-based prediction of c-Myc binding sites in the miR-3682-3p promoter region; C and D: RT-qPCR analysis of miR-3682-3p levels after c-Myc silencing and overexpression; E and F: Chromatin immunoprecipitation validated the binding of c-Myc to the miR-3682-3p promoter; G: Dual-luciferase reporter assay confirmed the binding of c-Myc to the miR-3682-3p promoter. aP < 0.05, bP < 0.01, cP < 0.001. Experiments were repeated three times. NC: Negative control.
- Citation: Chen Q, Yang SB, Zhang YW, Han SY, Jia L, Li B, Zhang Y, Zuo S. miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc. World J Stem Cells 2022; 14(7): 539-555
- URL: https://www.wjgnet.com/1948-0210/full/v14/i7/539.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v14.i7.539